Table 1.
Demographic and Clinical Characteristics of Patients With an Index Venous Thromboembolism
| DVT Only | PE With or Without DVT | Overall | ||||
|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |
| Total | 60 930 | 46.1 | 71 350 | 53.9 | 132 280 | 100 |
| Age, y | ||||||
| 18 to 64 | 36 731 | 60.3 | 47 520 | 66.6 | 84 251 | 63.7 |
| 65 to 74 | 7793 | 12.8 | 8978 | 12.6 | 16 771 | 12.7 |
| ≥75 | 16 406 | 26.9 | 14 852 | 20.8 | 31 258 | 23.6 |
| Sex (male) | 27 734 | 52.0 | 32 257 | 51.5 | 59 991 | 45.4 |
| Hypertension | 28 682 | 53.8 | 30 127 | 48.1 | 58 809 | 44.5 |
| Renal disease | 6365 | 11.9 | 3770 | 6.0 | 10 135 | 7.7 |
| Liver disease | 3826 | 7.2 | 3733 | 6.0 | 7559 | 5.7 |
| History of stroke | 6943 | 13.0 | 5470 | 8.7 | 12 413 | 9.4 |
| History of bleeding | 8076 | 15.2 | 7405 | 11.8 | 15 481 | 11.7 |
| Medication use (NSAIDs, antiplatelets) | 16 443 | 30.8 | 19 908 | 31.8 | 36 351 | 27.5 |
| Alcohol or drug use | 827 | 1.6 | 843 | 1.4 | 1670 | 1.3 |
| Cancer | 12 586 | 23.6 | 12 329 | 19.7 | 24 915 | 18.8 |
| Metastatic cancer | 4197 | 7.9 | 4317 | 6.9 | 8514 | 6.4 |
| HAS‐BLED Score | ||||||
| 0 | 12 564 | 23.6 | 18 023 | 28.8 | 30 587 | 23.1 |
| 1 | 16 424 | 30.8 | 20 858 | 33.3 | 37 282 | 28.2 |
| 2 | 14 536 | 27.3 | 15 282 | 24.4 | 29 818 | 22.5 |
| 3 | 7048 | 13.2 | 6389 | 10.2 | 13 437 | 10.2 |
| 4 | 2320 | 4.4 | 1786 | 2.9 | 4106 | 3.1 |
| 5 | 397 | 0.7 | 251 | 0.4 | 648 | 0.5 |
| 6 | 28 | 0.1 | 19 | 0.0 | 47 | 0.0 |
| 7 | 2 | 0.0 | ··· | ··· | 2 | 0.0 |
| Anticoagulation | ||||||
| LMWH | 5955 | 11.2 | 3980 | 6.4 | 9935 | 7.5 |
| NOAC | 8465 | 15.9 | 12 100 | 19.3 | 20 565 | 15.5 |
| Warfarin | 38 899 | 73.0 | 46 528 | 74.3 | 85 427 | 64.6 |
DVT indicates deep vein thrombosis; HAS‐BLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding, Labile International Normalized Ratio (INR), Elderly, Drugs or alcohol use; LMWH, low molecular weight heparin; NOAC, non‐vitamin K antagonist oral anticoagulant; PE, pulmonary embolism.